13F HOLDINGS REPORT (Amended)
BIOS Capital Management, LP
Quarter ended Q4 2024 · Filed February 18, 2025 · Accession 0001104659-25-014450
Total Value
$94.1M
Positions
9
Other Managers
1
Confidential Omitted
No
Holdings (9)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ACTUATE THERAPEUTICS INC | ACTU | 8,509,224 | $67.7M | 71.98% |
| 2 | ACTUATE THERAPEUTICS INC | ACTU | 1,384,427 | $11.0M | 11.71% |
| 3 | COGNITION THERAPEUTICS INC | CGTX | 5,499,905 | $3.9M | 4.10% |
| 4 | LANTERN PHARMA INC | LTRN | 1,207,709 | $3.9M | 4.09% |
| 5 | AILERON THERAPEUTICS INC | RNTX | 1,498,751 | $3.4M | 3.66% |
| 6 | IN8BIO INC | INAB | 8,600,001 | $2.2M | 2.35% |
| 7 | OPUS GENETICS INC | IRD | 995,249 | $1.2M | 1.26% |
| 8 | AILERON THERAPEUTICS INC | RNTX | 192,000 | $441,600 | 0.47% |
| 9 | COGNITION THERAPEUTICS INC | CGTX | 500,095 | $350,717 | 0.37% |